Development of a simplified, sensitive high-performance liquid chromatographic method using fluorescence detection to determine the concentration of UCN-01 in human plasma
- 3 August 2001
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 760 (2) , 247-253
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- A high-performance liquid chromatography method using ultraviolet and fluorescence detection for the quantitation of UCN-01, 7-hydroxystaurosporine, from human plasma and salivaBiomedical Chromatography, 2000
- Pharmacokinetics and pharmacodynamics of a novel protein kinase inhibitor, UCN-01Cancer Chemotherapy and Pharmacology, 1999
- UCN-01 Abrogates G2 Arrest through a Cdc2-dependent Pathway That Is Associated with Inactivation of the Wee1Hu Kinase and Activation of the Cdc25C PhosphataseJournal of Biological Chemistry, 1998
- Clinical pharmacology of UCN-01: Initial observations and comparison to preclinical modelsCancer Chemotherapy and Pharmacology, 1998
- Development of a highly sensitive high-performance liquid chromatographic method for measuring an anticancer drug, UCN-01, in human plasma or urineJournal of Chromatography B: Biomedical Sciences and Applications, 1998
- Activation of PKCα Downstream from Caspases during Apoptosis Induced by 7-Hydroxystaurosporine or the Topoisomerase Inhibitors, Camptothecin and Etoposide, in Human Myeloid Leukemia HL60 CellsJournal of Biological Chemistry, 1997
- Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitorJournal of Neurosurgery, 1996
- UCN-01, a selective inhibitor of protein kinase C from Streptomyces.The Journal of Antibiotics, 1987